Identification of a Novel ALK G1123S Mutation in a Patient with ALK-rearranged Non-small-cell Lung Cancer Exhibiting Resistance to Ceritinib.
Toyokawa, Gouji
Identification of a Novel ALK G1123S Mutation in a Patient with ALK-rearranged Non-small-cell Lung Cancer Exhibiting Resistance to Ceritinib. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Jul 2015 - e55-7 p. digital
Publication Type: Case Reports; Journal Article
1556-1380
10.1097/JTO.0000000000000509 doi
Anaplastic Lymphoma Kinase
Antineoplastic Agents--therapeutic use
Carcinoma, Non-Small-Cell Lung--drug therapy
Drug Resistance, Neoplasm
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Mutation
Pyrimidines--therapeutic use
Receptor Protein-Tyrosine Kinases--genetics
Sulfones--therapeutic use
Identification of a Novel ALK G1123S Mutation in a Patient with ALK-rearranged Non-small-cell Lung Cancer Exhibiting Resistance to Ceritinib. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Jul 2015 - e55-7 p. digital
Publication Type: Case Reports; Journal Article
1556-1380
10.1097/JTO.0000000000000509 doi
Anaplastic Lymphoma Kinase
Antineoplastic Agents--therapeutic use
Carcinoma, Non-Small-Cell Lung--drug therapy
Drug Resistance, Neoplasm
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Mutation
Pyrimidines--therapeutic use
Receptor Protein-Tyrosine Kinases--genetics
Sulfones--therapeutic use